BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9861286)

  • 1. Cameroon and Chad: cost recovery.
    Godin C
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S163-4. PubMed ID: 9861286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
    Amazigo U; Noma M; Boatin BA; Etya'alé DE; Sékétéli A; Dadzie KY
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S23-31. PubMed ID: 9861264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Onchocerciasis control program in Chad: the Mectizan donation].
    Namangué K
    Sante; 1998; 8(1):51-2. PubMed ID: 9592880
    [No Abstract]   [Full Text] [Related]  

  • 4. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.
    Utzinger J; Wyss K; Moto DD; Tanner M; Singer BH
    Clin Occup Environ Med; 2004 Feb; 4(1):9-26. PubMed ID: 15043361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement in the quality of life in rural Africa (AFRICARE) in the face of onchocerciasis in Chad (Mectizan donation program)].
    Meftuh AB
    Sante; 1998; 8(1):63. PubMed ID: 9592884
    [No Abstract]   [Full Text] [Related]  

  • 8. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
    Etya'alé DE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions--a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006).
    Katabarwa M; Habomugisha P; Eyamba A; Agunyo S; Mentou C
    Trop Med Int Health; 2010 Feb; 15(2):216-23. PubMed ID: 20002616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of Mectizan distribution.
    Waters HR; Rehwinkel JA; Burnham G
    Trop Med Int Health; 2004 Apr; 9(4):A16-25. PubMed ID: 15078276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of establishing community-directed treatment with Mectizan in Uganda.
    Okwero P
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mectizan delivery systems and cost recovery in the Central African Republic.
    Hopkins AD
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S97-100. PubMed ID: 9861274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?
    Okeibunor JC; Ogungbemi MK; Sama M; Gbeleou SC; Oyene U; Remme JH
    Trop Med Int Health; 2004 Aug; 9(8):887-96. PubMed ID: 15303994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
    Thylefors B; Alleman MM; Twum-Danso NA
    Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ivermectin on illness and disability associated with onchocerciasis.
    Tielsch JM; Beeche A
    Trop Med Int Health; 2004 Apr; 9(4):A45-56. PubMed ID: 15078278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
    Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The delivery of ivermectin (Mectizan).
    Burnham G; Mebrahtu T
    Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health: building on the success of PHC in Africa.
    Amaah SO
    New Afr; 1989 Jul; (262):4, 6. PubMed ID: 12283696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NGDO Co-ordination Group for Onchocerciasis Control.
    Haddad D
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():35-8. PubMed ID: 18718153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.